β¨ Medicines Act Consents
NEW ZEALAND GAZETTE
No. 57
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Gavilast 12 Hour Action
Active Ingredient:
Ranitidine hydrochloride 167.5mg/dose equivalent to ranitidine 150mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Reckitt Benckiser (New Zealand) Limited
Manufacturer:
Ranbaxy Laboratories Limited, Village Ganguwala, Paonta Sahib, District Sirmour, Himachal Pradesh, India
Product:
Junior Parapaed
Active Ingredient:
Paracetamol 2.4%w/v
Dosage Form:
Oral suspension
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland
Product:
Six Plus Parapaed
Active Ingredient:
Paracetamol 5%w/v
Dosage Form:
Oral suspension
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland
Dated this 21st day of May 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go3294
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Arrow β Ranitidine 150
Active Ingredient:
Ranitidine hydrochloride 168mg equivalent to ranitidine 150mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Arrow Pharmaceuticals Inc, Mississauga, Ontario, Canada
Product:
Arrow β Ranitidine 300
Active Ingredient:
Ranitidine hydrochloride 336mg equivalent to ranitidine 300mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Arrow Pharmaceuticals Inc, Mississauga, Ontario, Canada
Product:
Nodia
Active Ingredient:
Loperamide hydrochloride 2mg
Dosage Form:
Tablet
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Cipla Limited, Patalganga Industrial Area, District Raigad, Maharashtra, India
Product:
Refresh Liquigel
Active Ingredient:
Carmellose sodium 10mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan Inc., Waco, Texas, United States of America
Dated this 21st day of May 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go3293
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 57
Gazette.govt.nz —
NZ Gazette 2003, No 57
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare21 May 2003
Medicines Act 1981, New medicines, Distribution consent, Pharmaceuticals
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare21 May 2003
Medicines Act 1981, New medicines, Distribution consent, Pharmaceuticals
- G. R. Boyd, Chief Advisor, Safety and Regulation